Bayview Pharmacy is pleased to present our specially compounded Gabapentin 6%/Estriol 0.1%/Testosterone 0.1% Vaginal Gel, a unique formulation designed to alleviate symptoms associated with Vulvodynia, Atrophic Vaginitis, Dyspareunia, Lichen Sclerosus, and Genitourinary Syndrome of Menopause. This gel-like semisolid formulation is dispensed in a tube for easy and controlled application in the vaginal area, delivering medication or providing lubrication and therapeutic effects for various gynecological purposes.

The active ingredients in this formulation each play a crucial role in symptom relief. Gabapentin, an anticonvulsant, has been found effective in reducing pain associated with Vulvodynia. Estriol, a form of estrogen, works to reduce inflammation and improve the health of the vaginal tissue. Testosterone, a hormone, aids in improving libido and reducing vaginal dryness. Together, these ingredients work synergistically to provide relief from pain, itching, burning, and dryness associated with the aforementioned conditions.

This formulation is a potent treatment option for Vulvodynia, Atrophic Vaginitis, Dyspareunia, Lichen Sclerosus, and Genitourinary Syndrome of Menopause. However, it is crucial to remember that this formulation should only be used under the guidance of a healthcare provider. This ensures safe and effective use, tailored to your specific needs and health conditions.

If you have any questions about this formulation or are interested in learning more about how it can help treat these conditions, please do not hesitate to contact us at Bayview Pharmacy. Our team is dedicated to helping you find the best treatment options for your needs, providing comprehensive information and support throughout your treatment journey.

This compounded formulation of Gabapentin 6%/Estriol 0.1%/Testosterone 0.1% Vaginal Gel is a specialized, gel-like semisolid preparation, designed for easy and controlled application in the vaginal area. It is primarily used for the treatment of various gynecological conditions such as Vulvodynia, Atrophic Vaginitis, Dyspareunia, Lichen Sclerosus, and Genitourinary Syndrome of Menopause.

Gabapentin, an anticonvulsant, is a key component of this formulation and is known for its efficacy in reducing pain associated with Vulvodynia. Estriol, a weak estrogen, is used to treat Atrophic Vaginitis and Dyspareunia. Testosterone, another integral part of this formulation, is used to treat Lichen Sclerosus and Genitourinary Syndrome of Menopause.

It is crucial to note that this formulation is not recommended for use in pregnant women due to potential harm to the fetus. Patients using this formulation should be closely monitored for signs of hyperandrogenism, which may include symptoms such as hirsutism, acne, and alopecia. If any of these symptoms are observed, it is recommended that the patient be referred to an endocrinologist for further evaluation.

This formulation is a testament to the advancements in compounding pharmacy, providing targeted treatment for specific gynecological conditions. However, it is always recommended to consult with a healthcare provider before starting any new medication regimen.

Gabapentin 6%/Estriol 0.1%/Testosterone 0.1% Vaginal Gel is a specially compounded medication designed to address a range of vulvovaginal health conditions. This unique formulation combines three active ingredients: Gabapentin, Estriol, and Testosterone, each playing a crucial role in providing relief and therapeutic effects.

Gabapentin, an anticonvulsant, works to alleviate pain and inflammation. Estriol, a form of estrogen, is instrumental in reducing symptoms associated with atrophic vaginitis, such as dryness, itching, and burning. Testosterone, on the other hand, aids in enhancing libido and sexual function.

This combination of medications is particularly effective in reducing symptoms of various conditions including vulvodynia, atrophic vaginitis, dyspareunia, lichen sclerosus, and genitourinary syndrome of menopause. The gel-like semisolid formulation is dispensed in a tube for easy and controlled application in the vaginal area, ensuring precise delivery of medication.

It is crucial to adhere to the instructions provided by your healthcare provider when using this formulation. The gel should be applied to the affected area once or twice daily, depending on the severity of the condition. It is important to use the gel as directed, as using too much or too little can lead to side effects. Please note that this medication should not be used during pregnancy or breastfeeding.

This formulation is an effective treatment for a variety of conditions related to vulvovaginal health. It can help reduce symptoms of vulvodynia, atrophic vaginitis, dyspareunia, lichen sclerosus, and genitourinary syndrome of menopause. If you have any questions about this formulation or how to use it, please consult with your healthcare provider.

This compounded formulation of Gabapentin 6%/Estriol 0.1%/Testosterone 0.1% Vaginal Gel is a gel-like semisolid substance, specifically designed for easy and controlled application in the vaginal area. It is dispensed in a tube and is used for delivering medication, providing lubrication, and offering therapeutic effects for various gynecological purposes. It has been effectively used in the treatment of conditions such as Vulvodynia, Atrophic Vaginitis, Dyspareunia, Lichen Sclerosus, and Genitourinary Syndrome of Menopause. It has also shown efficacy in treating other conditions like vulvar vestibulitis, lichen planus, and postmenopausal vaginal dryness.

Furthermore, this formulation has been found to be beneficial in reducing pain and discomfort associated with sexual intercourse. It has shown promising results in alleviating symptoms of vaginal atrophy, such as dryness, itching, burning, and dyspareunia. It may also be used to reduce the risk of recurrent urinary tract infections and recurrent bacterial vaginosis. This formulation should be used as directed by a healthcare provider. If you have any questions about the use of this formulation, please consult with your healthcare provider.